Saranholi Taís Lopes, Sampaio Natalie Carlos Ferreira Mello, Miot Hélio Amante, Dantas Stéfani Thais Alves, Rall Vera Lucia Mores, Abbade Luciana Patricia Fernandes
Nursing Department, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil.
Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil.
An Bras Dermatol. 2025 Jul 14;100(5):501162. doi: 10.1016/j.abd.2025.501162.
Superficial infection in venous ulcers (VU) hinders healing.
To evaluate the action of hydrofiber dressing with silver (HAg) compared to collagenase ointment (Col) in VU.
Randomized controlled clinical trial in which patients with VU with superficial infection were randomized to the intervention (HAg) or comparison (Col) group. After 30 days (T30), the primary outcomes evaluated were: rate of ulcers without signs of superficial infection, decrease in bacterial load, presence of biofilm-producing bacteria, and bacterial clonality.
Thirty-four patients (56 ulcers) were included ‒ 18 patients (28 ulcers) in the HAg group and 16 (28 ulcers) in the Col group. There was a reduction in ulcers with superficial infection in both groups over time but with no differences (p = 0.422). There was no decrease in total bacterial load over time (p = 0.054) or between the groups (p = 0.113). There was a reduction in the rate of ulcers with biofilm-forming bacteria over time (p = 0.047) but no differences between groups (p = 0.558). Regarding the clonality of Staphylococcus aureus, 92.8% of ulcers in the HAg group and 85% in the Col group, the clones identified at T0 were the same at T30 (p = 0.553). There was no change in the identity of Pseudomonas aeruginosa in any ulcer in either group.
Short follow-up time.
Both interventions improved the clinical and some microbiologic characteristics, but there was no difference between both interventions. In addition, most ulcers showed indistinguishable genetic profiles of S. aureus and P. aeruginosa between T0 and T30, with no difference between the groups.
静脉溃疡(VU)的浅表感染会阻碍愈合。
评估含银水凝胶敷料(HAg)与胶原酶软膏(Col)相比在静脉溃疡中的作用。
进行随机对照临床试验,将患有浅表感染的静脉溃疡患者随机分为干预组(HAg)或对照组(Col)。30天后(T30),评估的主要结局包括:无浅表感染迹象的溃疡率、细菌载量的降低、产生物膜细菌的存在情况以及细菌克隆性。
纳入34例患者(56处溃疡),HAg组18例患者(28处溃疡),Col组16例患者(28处溃疡)。随着时间推移,两组浅表感染溃疡均减少,但无差异(p = 0.422)。随着时间推移以及两组之间,总细菌载量均未降低(p = 0.054和p = 0.113)。随着时间推移,产生物膜细菌的溃疡率降低(p = 0.047),但两组之间无差异(p = 0.558)。关于金黄色葡萄球菌的克隆性,HAg组92.8%的溃疡和Col组85%的溃疡,在T0时鉴定出的克隆在T30时相同(p = 0.553)。两组中任何溃疡的铜绿假单胞菌身份均无变化。
随访时间短。
两种干预措施均改善了临床和一些微生物学特征,但两种干预措施之间无差异。此外,大多数溃疡在T0和T30之间金黄色葡萄球菌和铜绿假单胞菌的基因谱无差异,两组之间也无差异。